Literature DB >> 29191489

Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis.

Katie L Owen1, Belinda S Parker2.   

Abstract

Bone metastasis is a fatal consequence of a subset of solid malignancies that fail to respond to conventional therapies. While a myriad of factors contribute to osteotropism and disseminated cell survival and outgrowth in bone, efforts to inhibit tumor cell growth in the bone-metastatic niche have largely relied on measures that disrupt the bi-directional interactions between bone resident and tumor cells. However, the targeting of isolated stromal interactions has proven ineffective to date in inhibiting bone-metastatic progression and patient mortality. Osteoimmune regulation is now emerging as a critical determinant of metastatic growth in the bone microenvironment. While this has highlighted the importance of innate immune populations in dictating the temporal development of overt bone metastases, the osteoimmunological processes that underpin tumor cell progression in bone remain severely underexplored. Along with tumor-intrinsic alterations that occur specifically within the bone microenvironment, innate osteoimmunological crosstalk poses an exciting area of future discovery and therapeutic development. Here we review current knowledge of the unique exchange that occurs between bone resident cells, innate immune populations and tumor cells that leads to the establishment of a tumor-permissive milieu.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone metastasis; Breast cancer; Innate immunity; Interferon; Prostate cancer; TGF-&beta

Mesh:

Year:  2017        PMID: 29191489     DOI: 10.1016/j.molimm.2017.11.023

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  The pathways and mechanisms of muramyl dipeptide transcellular transport mediated by PepT1 in enterogenous infection.

Authors:  Guo-Guang Ma; Bin Shi; Xue-Peng Zhang; Yue Qiu; Guo-Wei Tu; Zhe Luo
Journal:  Ann Transl Med       Date:  2019-09

Review 2.  Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases.

Authors:  Ilaria Roato; Riccardo Ferracini
Journal:  Cancers (Basel)       Date:  2018-02-20       Impact factor: 6.639

3.  Unexpected Response to Nivolumab in a "Fast Progressor" Head and Neck Cancer Patient.

Authors:  Martina Napolitano; Lucia Trudu; Federica Bertolini
Journal:  Case Rep Oncol       Date:  2019-09-17

Review 4.  Bone Metastasis: Current State of Play.

Authors:  Anthony Turpin; Martine Duterque-Coquillaud; Marie-Hélène Vieillard
Journal:  Transl Oncol       Date:  2019-12-23       Impact factor: 4.243

Review 5.  Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment.

Authors:  Ushashi C Dadwal; Eric S Chang; Uma Sankar
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-18       Impact factor: 5.555

6.  Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis.

Authors:  Lea Monteran; Nour Ershaid; Idan Sabah; Ibrahim Fahoum; Yael Zait; Ophir Shani; Noam Cohen; Anat Eldar-Boock; Ronit Satchi-Fainaro; Neta Erez
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

Review 7.  Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management.

Authors:  Barbara Altieri; Carla Di Dato; Chiara Martini; Concetta Sciammarella; Antonella Di Sarno; Annamaria Colao; Antongiulio Faggiano
Journal:  Cancers (Basel)       Date:  2019-09-08       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.